NIH-funded research R01 grant

Understanding how lung cells become activated in fibrosis

Official title: Fibrogenic activation and memory in the lung mesenchyme

Funded at Mayo Clinic Rochester · NIH-11001577 · Data updated 2026-11-12

This study is looking into how certain cells in the lungs, called fibroblasts, get turned on and stay active in conditions like pulmonary fibrosis, and it’s for anyone interested in understanding why lung problems can get worse over time.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startDecember 1, 2022
Project endNovember 30, 2026
Funding year2025
Award (this year)$536,436
NIH project number5R01HL166187-03
Project IDNIH-11001577 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with interstitial lung diseases, particularly those with pulmonary fibrosis.

Less likely to help

Patients with acute lung injuries or those without a diagnosis of interstitial lung disease may not benefit from this research.

What this research studies

This research investigates the mechanisms behind the activation of fibroblasts in the lungs, particularly in conditions like pulmonary fibrosis. It aims to understand how these cells can become persistently activated, leading to worsening lung conditions. By studying the role of a specific transcription factor called Runx1, the research will explore how fibroblasts remember their activated state and respond to repeated lung injuries. The approach includes using mouse models to track changes in fibroblast behavior during the progression of lung fibrosis.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that fundamentally alter the course of fibrotic lung diseases, improving patient outcomes.

How similar studies have gone: Previous research has shown promising results in understanding fibroblast activation in other contexts, suggesting potential for success in this area.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Tschumperlin, Daniel J. — Mayo Clinic Rochester
  • Study coordinator: Tschumperlin, Daniel J.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.